Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study.


Journal

The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003

Informations de publication

Date de publication:
04 2021
Historique:
received: 30 10 2020
revised: 14 12 2020
accepted: 21 12 2020
pubmed: 9 2 2021
medline: 2 4 2021
entrez: 8 2 2021
Statut: ppublish

Résumé

During the COVID-19 lockdown period from March 17 to May 11, 2020, French authorities in Paris and its suburbs relocated people experiencing recurrent homelessness to emergency shelters, hotels, and large venues. A serological survey was done at some of these locations to assess the COVID-19 exposure prevalence in this group. We did a cross-sectional seroprevalence study at food distribution sites, emergency shelters, and workers' residences that were provided medical services by Médecins Sans Frontières in Paris and Seine-Saint-Denis in the Ile-de-France region. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody seropositivity was detected by Luciferase-Linked Immunosorbent Assay and Pseudo Neutralization Test. Sociodemographic and exposure related information was collected via a verbal questionnaire to analyse risk factors and associations with various COVID-19 symptoms. Between June 23 and July 2, 2020, 426 (52%) of 818 individuals recruited tested positive in 14 sites. Seroprevalence varied significantly by type of recruitment site (χ These results show high exposure to SARS-CoV-2 with important variations between those at different study sites. Living in crowded conditions was the strongest factor associated with exposure level. This study underscores the importance of providing safe, uncrowded accommodation, alongside adequate testing and public health information. Médecins Sans Frontières, Epicentre, Institut Pasteur's URGENCE nouveau coronavirus fund, Total Foundation.

Sections du résumé

BACKGROUND
During the COVID-19 lockdown period from March 17 to May 11, 2020, French authorities in Paris and its suburbs relocated people experiencing recurrent homelessness to emergency shelters, hotels, and large venues. A serological survey was done at some of these locations to assess the COVID-19 exposure prevalence in this group.
METHODS
We did a cross-sectional seroprevalence study at food distribution sites, emergency shelters, and workers' residences that were provided medical services by Médecins Sans Frontières in Paris and Seine-Saint-Denis in the Ile-de-France region. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody seropositivity was detected by Luciferase-Linked Immunosorbent Assay and Pseudo Neutralization Test. Sociodemographic and exposure related information was collected via a verbal questionnaire to analyse risk factors and associations with various COVID-19 symptoms.
FINDINGS
Between June 23 and July 2, 2020, 426 (52%) of 818 individuals recruited tested positive in 14 sites. Seroprevalence varied significantly by type of recruitment site (χ
INTERPRETATION
These results show high exposure to SARS-CoV-2 with important variations between those at different study sites. Living in crowded conditions was the strongest factor associated with exposure level. This study underscores the importance of providing safe, uncrowded accommodation, alongside adequate testing and public health information.
FUNDING
Médecins Sans Frontières, Epicentre, Institut Pasteur's URGENCE nouveau coronavirus fund, Total Foundation.

Identifiants

pubmed: 33556328
pii: S2468-2667(21)00001-3
doi: 10.1016/S2468-2667(21)00001-3
pmc: PMC7993986
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202-e209

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Thomas Roederer (T)

Epicentre, Paris, France. Electronic address: thomas.roederer@epicentre.msf.org.

Bastien Mollo (B)

Médecins Sans Frontières, Paris, France.

Charline Vincent (C)

Médecins Sans Frontières, Paris, France.

Birgit Nikolay (B)

Epicentre, Paris, France.

Augusto E Llosa (AE)

Epicentre, Paris, France.

Robin Nesbitt (R)

Epicentre, Paris, France.

Jessica Vanhomwegen (J)

Environment and Infectious Risks Research and Expertise Unit, Global Health Department, Institut Pasteur, Paris, France.

Thierry Rose (T)

Unit of Lymphocyte Cell Biology, Immunology Department, Institut Pasteur, Paris, France.

Sophie Goyard (S)

Unit of Lymphocyte Cell Biology, Immunology Department, Institut Pasteur, Paris, France.

François Anna (F)

Unit of Molecular Virology and Vaccinology, Virology Department, Institut Pasteur, Paris, France; Theravectys, Paris, France.

Corinne Torre (C)

Médecins Sans Frontières, Paris, France.

Emilie Fourrey (E)

Médecins Sans Frontières, Paris, France.

Erica Simons (E)

Epicentre, Paris, France.

William Hennequin (W)

Médecins Sans Frontières, Paris, France.

Clair Mills (C)

Médecins Sans Frontières, Paris, France.

Francisco J Luquero (FJ)

Epicentre, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH